Oncopeptides
Presence
Oncopeptides is a company listed under the stock ticker ONCO (SE).
Executives
View the org chart displaying its 13 main executives
Most searched biographies at Oncopeptides
Popular executive movements at Oncopeptides
- Henrik Bergentoft has joined the company as Chief Financial Officer (posted on August 9 2023).
- Sofia Heigis, who was Chief Commercial Officer and Managing Director, Germany, is promoted to Chief Executive Officer (posted on August 8 2023).
Create your alert
to follow the executive moves at Oncopeptides.
Biotechnology
Oncopeptides has 2,275 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Bruker has announced the acquisition of NanoString Technologies (posted on April 18 2024).
- Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences (posted on April 16 2024).
- Nurix Therapeutics has just announced a $175 Million fundraising (posted on April 13 2024).
Popular contacts in Biotechnology
News
Press releases by Oncopeptides
- Oncopeptides releases first quarter 2024 sales - Oncopeptides
- Oncopeptides announces final terms for the fully guaranteed rights issue - Oncopeptides
- Oncopeptides and Vector Pharma FZCO Announce Collaboration to Provide Pepaxti to Patients in the Middle East and North Africa - Oncopeptides
- Extraordinary General Meeting in Oncopeptides AB (publ) - Oncopeptides
- Oncopeptides carries out a fully guaranteed rights issue of approximately SEK 300 million to reach profitability during 2026 - Oncopeptides
- Oncopeptides receives decision from the U.S. Food and Drug Administration confirming withdrawal of Pepaxto from the U.S. market - Oncopeptides
- Oncopeptides receives positive recommendation for Pepaxti by Spanish Pricing Authority - Oncopeptides
- Oncopeptides’ PORT study shows peripheral administration of Pepaxti being equally safe as central venous administration - Oncopeptides
- Oncopeptides publishes year-end report 2023 - Oncopeptides
- Pepaxti provides sustained health related Quality of Life OCEAN study shows, article published in Haematologica - Oncopeptides
- View more press releases Close
Social media about Oncopeptides
- Oncopeptides on Wikipedia, Google News & Yahoo Finance
- Oncopeptides on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Sofia Heigis 
